Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated ...
Pfizer (NYSE:PFE) has reportedly agreed to pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer risks associated with its now-discontinued heartburn ...
, opens new tab will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. PFE has agreed to pay up to $250 million. What Happened: The settlement, disclosed in a Delaware ...
(Reuters) -Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on ...
Secondo il Financial Times, l’accordo mira a ridurre in modo sostanziale la responsabilità di Pfizer. L’azienda ha sottolineato che i suoi prodotti Zantac sono stati esaminati e approvati dalla Food ...
Nel tentativo di risolvere migliaia di cause legali relative al suo farmaco per il bruciore di stomaco Zantac, ormai in disuso, Pfizer Inc. (NYSE:PFE) ha accettato di pagare fino a 250 milioni di ...
(Reuters) -Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on ...
Le azioni dell’azienda hanno perso il 27 per cento di valore negli ultimi 12 mesi alla chiusura della Borsa di mercoledì, e all’apertura dei mercati di oggi sono scese di altri 1,5 punti ...